Mibefradil inhibition of T-type calcium channels in cerebellar Purkinje neurons

Molecular Pharmacology

Volumn 54, Issue 6, 1998, Pages 1080-1087

  McDonough, Stefan I ^a   Bean, Bruce P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL; ETHOSUXIMIDE; MIBEFRADIL;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CEREBELLUM; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; ELECTRIC POTENTIAL; HYPERPOLARIZATION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; RAT;

EID: 0032407483     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.6.1080     Document Type: Article

References (21)

1. Bean BP, Cohen CJ, and Tsien RW (1983) Lidocaine block of cardiac sodium channels. J Gen Physiol 81:613-642.
2. Bénardeau A and Ertel EA (1998) Selective block of myocardial T-type calcium channels by mibefradil: a comparison with the 1,4-dihydropyridine amlodipine, in Low-Voltage-Activated T-Type Calcium Channels (Tsien RW, Clozel J-P, and Nargeot J, eds) pp 386-394, Adis International, Chester, England.
3. 2+ channel antagonist mibefradil (Ro 40-5967). Mol Pharmacol 48:540-549.
4. 2+ channel antagonist Ro 40-5967 in vascular muscle cells cultured from dog coronary and saphenous arteries. Naunyn-Schmiedebergs Arch Pharmacol 348: 191-196.
5. Clozel JP, Ertel EA, and Ertel SI (1997) Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker. J Hypertens 15(Suppl):S17-S25.
6. Clozel J-P, Osterrieder W, Kleinbloesem CH, Welker HA, Schlappi B, Tudor R, Hefti F, Schmitt R, and Eggers H (1991) Ro 40-5967: a new nondihydropyridine calcium antagonist. Cardiovasc Drug Rev 9:4-17.
7. Coulter DA, Huguenard JR, and Prince DA (1990) Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: calcium current reduction. Br J Pharmacol 100:800-806.
8. 2+ channels in mammalian central neurons. Trends Neurosci 18:89-98.
9. * channels. Trends Pharmacol Sci 18:37-42.
10. 2+ channels and pharmacological blockade: potential pathophysiological relevance. Cardiovasc Drugs Ther 11:723-739.
11. 2+ inward currents by Ro 40-5967 and verapamil: relation to negative inotropy, Eur J Pharmacol 196:205-207.
12. Fox AP, Nowycky MC, and Tsien RW (1987) Single-channel recordings of three types of calcium channels in chick sensory neurones. J Physiol (Lond) 394:173-200.
13. Ghosh A and Greenberg ME (1995) Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science (Washington DC) 268:239-247.
14. Hermsmeyer K, Mishra S, Miyagawa K, and Minshall R (1997) Physiologic and pathophysiologic relevance of T-type calcium-ion channels: potential indications for T-type calcium antagonists. Clin Ther 19:18-26.
15. 2+ channels. Neuron 9:69-77.
16. 2+ channel diversity. Annu Rev Neurosci 17:399-418.
17. Huguenard JR (1996) Low-threshold calcium currents in central nervous system neurons. Annu Rev Physiol 58:329-348.
18. Kaneda M, Wakamori M, Ito C, and Akaike N (1990) Low-threshold calcium current in isolated Purkinje cell bodies of rat cerebellum. J Neurophysiol 63:1046-1051.
19. McCobb DP, Best PM, and Beam KG (1989) Development alters the expression of calcium currents in chick limb motoneurons. Neuron 2:1633-1643.
20. McDonough SI, Swartz KJ, Mintz IM, Boland LM, and Bean BP (1996) Inhibition of calcium channels in rat central and peripheral neurons by ω-conotoxin MVIIC. J Neurosci 16:2612-2623.
21. ++ channels. J Pharmacol Exp Ther 271:1483-1488.